We here showed that Akt-mTOR inactivation, JNK activation and oxidative injury were detected in SKI-349-treated NSCLC cells and SKI-349-administrated pNSCLC-1 xenograft tissues. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.